Form 4 for EW Edwards Lifesciences
Accepted 2024-02-26 00:00:00 ET · period of report 2024-02-23 · accession 0001225208-24-002963 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-26 | 2024-02-23 | EW | GALLAHUE KIERAN | Dir | M - OptEx | $36.86 | +7,056 | 10.8K | +191% | +$260.1K |
| D | 2024-02-26 | 2024-02-23 | EW | GALLAHUE KIERAN | Dir | G - Gift | $0.00 | -7,056 | 3,701 | -66% | $0 |
| DI | 2024-02-26 | 2024-02-23 | EW | GALLAHUE KIERAN | Dir | S - Sale+OE | $87.61 | -3,058 | 67.2K | -4% | -$267.9K |
| DI | 2024-02-26 | 2024-02-23 | EW | GALLAHUE KIERAN | Dir | G - Gift | $0.00 | +7,056 | 70.3K | +11% | $0 |
| D | 2024-02-26 | 2024-02-23 | EW | GALLAHUE KIERAN | Dir | M - OptEx | $0.00 | -7,056 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-23 | M | A | 7,056 | $36.86 | 10,757 | D By Trust | — | — | |
| 2 | Common | Common Stock | 2024-02-23 | G | D | 7,056 | $0.00 | 3,701 | D By Trust | — | — | |
| 3 | Common | Common Stock | 2024-02-23 | S | D | 3,058 | $87.61 | 67,219 | I | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $87.5908 to $87.6210. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2024-02-23 | G | A | 7,056 | $0.00 | 70,277 | I | — | — | |
| 5 | Derivative | Director Stock Option (Right to Acquire) | 2024-02-23 | M | D | 7,056 | $0.00 | 0 | D | $36.86 · 2017-05-12 to 2024-05-11 | 7,056 Common Stock |